Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA
T Poovelikunnel1, G Gethin2, H Humphreys3
1Infection Prevention and Control Department, Beaumont Hospital, Dublin, Ireland Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland toneythomas@beaumont.ie.
Abstract:
Mupirocin 2% ointment is used either alone or with skin antiseptics as part of a comprehensive MRSA decolonization strategy. Increased mupirocin use predisposes to mupirocin resistance, which is significantly associated with persistent MRSA carriage. Mupirocin resistance as high as 81% has been reported. There is a strong association between previous mupirocin exposure and both low-level and high-level mupirocin resistance. High-level mupirocin resistance (mupA carriage) is also linked to MDR. Among MRSA isolates, the presence of the qacA and/or qacB gene, encoding resistance to chlorhexidine, ranges from 65% to 91%, which, along with mupirocin resistance, is associated with failed decolonization. This is of significant concern for patient care and infection prevention and control strategies as both these agents are used concurrently for decolonization. Increasing bacterial resistance necessitates the discovery or development of new antimicrobial therapies. These include, for example, polyhexanide, lysostaphin, ethanol, omiganan pentahydrochloride, tea tree oil, probiotics, bacteriophages and honey. However, few of these have been evaluated fully or extensively tested in clinical trials and this is required to in part address the implications of mupirocin resistance.
Insights
Mupirocin resistance is rising, linked to persistent MRSA carriage and failed decolonization. New antimicrobial therapies are needed to combat resistance and improve infection control.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Mupirocin 2% ointment is a key component of MRSA decolonization strategies.
- Increased mupirocin use correlates with rising mupirocin resistance.
- Mupirocin resistance is associated with persistent MRSA carriage and treatment failure.
Purpose of the Study:
- To investigate the prevalence and implications of mupirocin resistance in MRSA.
- To examine the association between mupirocin resistance, qacA/qacB genes, and decolonization failure.
- To highlight the need for novel antimicrobial therapies.
Main Methods:
- Analysis of mupirocin resistance rates in MRSA isolates.
- Assessment of the association between mupirocin exposure and resistance.
- Evaluation of co-resistance to chlorhexidine (qacA/qacB genes) and its impact on decolonization.
Main Results:
- Mupirocin resistance rates up to 81% have been reported.
- Previous mupirocin exposure is strongly linked to both low-level and high-level resistance.
- High-level mupirocin resistance (mupA carriage) is associated with multidrug resistance (MDR).
- Prevalence of qacA/qacB genes ranges from 65% to 91%, associated with failed decolonization alongside mupirocin resistance.
Conclusions:
- Rising mupirocin resistance and co-resistance to antiseptics compromise MRSA decolonization.
- This resistance poses a significant threat to patient care and infection control.
- Development and clinical evaluation of alternative antimicrobial therapies are urgently required.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Hand hygiene
Hand washing...

